P100 Latency Prolongation and Amplitude Reduction in Patients with RRMS
In a study of 83 patients with relapsing-remitting MS over two years, 43.4% developed prolonged P100 latency, linked to a higher relapse rate (OR 2.91, p = 0.005). Additionally, 56.6% showed reduced amplitude, associated with greater disability, but these findings were not robust after multiple comparisons and adjustments.